Alvotech (ALVOW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 23Jul 30Aug 14Aug 20Aug 25Sep 3Sep 14Sep 18

Key dataSep 18, 2026

Open$1.52

From 52W high−86.09%

Volume11455.00

Market cap$111.09M

P/E (TTM)—

P/S (TTM)0.2x

Div yield—

Key dataSep 18, 2026

Open

$1.52

From 52W high

−86.09%

Volume

11455.00

Market cap

$111.09M

ValuationView details →

P/E (Fwd)

2.3x

EV/EBITDA

−996.6x

P/E (TTM)

—

RSI (14)

57.9

MomentumView details →

1D Return

+19.36%

YTD Return

−41.54%

ValuationView details →

P/E (Fwd)

2.3x

P/E (TTM)

—

EV/EBITDA

−996.6x

EV/Sales

2.9x

P/S (TTM)

0.2x

P/B (TTM)

−0.6x

ProfitabilityView details →

Gross Margin

60.45%

Net Margin

−36.51%

EBITDA Margin

−0.29%

ROE (TTM)

93.79%

ROA (TTM)

−11.31%

Asset Turnover

0.33x

GrowthView details →

Revenue YoY

−12.17%

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

+91.85%

EPS CAGR 3Y

+111.49%

EBITDA YoY

—

MomentumView details →

1D Return

+19.36%

YTD Return

−41.54%

1Y Return

−65.15%

RSI (14)

57.9

vs 50D SMA

+47.13%

vs 200D SMA

−24.12%

Capital & dividendView details →

Debt/Equity

−7.58x

Current Ratio

1.65x

Quick Ratio

0.96x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.09

EPS Surprise

−74.77%

Beats (12Q)

2/12

Next Q EPS Est

−$0.03

Avg Surprise (4Q)

−2218.09%

Rev Surprise

2.91%

Financials snapshotView financials →

Revenue (TTM)

491.95M

Net Income (TTM)

−179.59M

Op. CF (TTM)

−198.70M

Next earningsNov 11, 2026 →

Latest newsMore news →

Fuji Pharma obtained manufacturing and marketing approval in Japan for two biosimilar products, ustekinumab BS 130mg intravenous infusion and golimumab BS 50mg subcutaneous autoinjector.2d ago

Alvotech shares rose 5.58% to $5.30 in after-hours trading on September 16, 2026, ahead of an FDA review decision.4d ago

Similar companies

Cumberland Pharmaceuticals Inc.CPIX PuraPharm Corporation Limited01498.HK BGM Group Ltd.BGM Procaps Group S.A.PROC Huakang Biomedical Holdings Company Limited08622.HK Organigram Global Inc.OGI Find similar companies →

Latest newsMore news →

Fuji Pharma obtained manufacturing and marketing approval in Japan for two biosimilar products, ustekinumab BS 130mg intravenous infusion and golimumab BS 50mg subcutaneous autoinjector.2d ago Alvotech shares rose 5.58% to $5.30 in after-hours trading on September 16, 2026, ahead of an FDA review decision.4d ago Alvotech announced its financial results for the first half of 2026 and provided a business update on August 19, 2026.32d ago